These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33262770)

  • 1. Siplizumab, an Anti-CD2 Monoclonal Antibody, Induces a Unique Set of Immune Modulatory Effects Compared to Alemtuzumab and Rabbit Anti-Thymocyte Globulin
    Binder C; Sellberg F; Cvetkovski F; Berglund E; Berglund D
    Front Immunol; 2020; 11():592553. PubMed ID: 33262770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Siplizumab Induces NK Cell Fratricide Through Antibody-Dependent Cell-Mediated Cytotoxicity.
    Binder C; Sellberg F; Cvetkovski F; Berg S; Berglund E; Berglund D
    Front Immunol; 2021; 12():599526. PubMed ID: 33643309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Siplizumab selectively depletes effector memory T cells and promotes a relative expansion of alloreactive regulatory T cells in vitro.
    Podestà MA; Binder C; Sellberg F; DeWolf S; Shonts B; Ho SH; Obradovic A; Waffarn E; Danzl N; Berglund D; Sykes M
    Am J Transplant; 2020 Jan; 20(1):88-100. PubMed ID: 31319439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Siplizumab combination therapy with belatacept or abatacept broadly inhibits human T cell alloreactivity in vitro.
    Cvetkovski F; Razavi R; Sellberg F; Berglund E; Berglund D
    Am J Transplant; 2023 Oct; 23(10):1603-1611. PubMed ID: 37270108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged lymphocyte depletion by single-dose rabbit anti-thymocyte globulin and alemtuzumab in kidney transplantation.
    Sageshima J; Ciancio G; Guerra G; Gaynor JJ; Cova D; Zarak A; Chen L; Mattiazzi A; Kupin W; Roth D; Hanson L; Livingstone AS; Ruiz P; Burke GW
    Transpl Immunol; 2011 Sep; 25(2-3):104-11. PubMed ID: 21784152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of natural killer cells by rabbit antithymocyte globulin and campath-1H: similar effects independent of specificity.
    Stauch D; Dernier A; Sarmiento Marchese E; Kunert K; Volk HD; Pratschke J; Kotsch K
    PLoS One; 2009; 4(3):e4709. PubMed ID: 19266059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of terminal complement blockade on the efficacy of induction with polyclonal rabbit antithymocyte globulin in living donor renal allografts.
    Goh BK; Chedid MF; Gloor JM; Raghavaiah S; Stegall MD
    Transpl Immunol; 2012 Oct; 27(2-3):95-100. PubMed ID: 22813834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humanized anti-CD2 monoclonal antibody treatment of plaque psoriasis: efficacy and pharmacodynamic results of two randomized, double-blind, placebo-controlled studies of intravenous and subcutaneous siplizumab.
    Bissonnette R; Langley RG; Papp K; Matheson R; Toth D; Hultquist M; Geba GP; White B
    Arch Dermatol Res; 2009 Jul; 301(6):429-42. PubMed ID: 19471949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic study of a clinically effective anti-CD2 monoclonal antibody.
    Sellberg F; Berglund D; Binder C; Hope J; Fontenot J; Griesemer A; Sykes M; Sachs DH; Berglund E
    Scand J Immunol; 2020 Jan; 91(1):e12839. PubMed ID: 31630416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In kidney transplant patients, alemtuzumab but not basiliximab/low-dose rabbit anti-thymocyte globulin induces B cell depletion and regeneration, which associates with a high incidence of de novo donor-specific anti-HLA antibody development.
    Todeschini M; Cortinovis M; Perico N; Poli F; Innocente A; Cavinato RA; Gotti E; Ruggenenti P; Gaspari F; Noris M; Remuzzi G; Casiraghi F
    J Immunol; 2013 Sep; 191(5):2818-28. PubMed ID: 23913968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety profile, pharmacokinetics, and pharmacodynamics of siplizumab, a humanized anti-CD2 monoclonal antibody, in renal allograft recipients.
    Pruett TL; McGory RW; Wright FH; Pescovitz MD; Yang H; McClain JB
    Transplant Proc; 2009 Nov; 41(9):3655-61. PubMed ID: 19917362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depleting antibody induction in simultaneous pancreas-kidney transplantation: a prospective single-center comparison of alemtuzumab versus rabbit anti-thymocyte globulin.
    Stratta RJ; Rogers J; Orlando G; Farooq U; Al-Shraideh Y; Doares W; Kaczmorski S; Farney AC
    Expert Opin Biol Ther; 2014 Dec; 14(12):1723-30. PubMed ID: 25156622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alemtuzumab in Multiple Sclerosis: Short- and Long-Term Effects of Immunodepletion on the Peripheral Treg Compartment.
    Haas J; Würthwein C; Korporal-Kuhnke M; Viehoever A; Jarius S; Ruck T; Pfeuffer S; Meuth SG; Wildemann B
    Front Immunol; 2019; 10():1204. PubMed ID: 31214176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα-CD47 innate immune checkpoint.
    Voets E; Paradé M; Lutje Hulsik D; Spijkers S; Janssen W; Rens J; Reinieren-Beeren I; van den Tillaart G; van Duijnhoven S; Driessen L; Habraken M; van Zandvoort P; Kreijtz J; Vink P; van Elsas A; van Eenennaam H
    J Immunother Cancer; 2019 Dec; 7(1):340. PubMed ID: 31801627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety profile of intravenous and subcutaneous siplizumab, an anti-CD2 monoclonal antibody, for the treatment of plaque psoriasis: results of two randomized, double-blind, placebo-controlled studies.
    Langley RG; Papp K; Bissonnette R; Toth D; Matheson R; Hultquist M; White B
    Int J Dermatol; 2010 Jul; 49(7):818-28. PubMed ID: 20618506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of rabbit anti-human thymocyte globulin on lymphocyte subpopulations and functions following allotransplantation in the rhesus monkey.
    Thomas JM; Carver M; Scott J; Williams E; Thomas F
    Transplantation; 1979 Mar; 27(3):163-70. PubMed ID: 107631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rabbit antithymocyte globulin induces human lymphocyte activation, proliferation, and apoptosis in the absence of complement: an experimental study.
    Tan X; Feng H; Guo Z; Wang L; Fu C; Sun L; Li Y; Xia Q; Hou L; Liu C; Zhu L; Chen G
    Transpl Int; 2021 May; 34(5):930-941. PubMed ID: 33725365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD2 Immunobiology.
    Binder C; Cvetkovski F; Sellberg F; Berg S; Paternina Visbal H; Sachs DH; Berglund E; Berglund D
    Front Immunol; 2020; 11():1090. PubMed ID: 32582179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATG-induced expression of FOXP3 in human CD4(+) T cells in vitro is associated with T-cell activation and not the induction of FOXP3(+) T regulatory cells.
    Broady R; Yu J; Levings MK
    Blood; 2009 Dec; 114(24):5003-6. PubMed ID: 19822903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine antithymocyte globulin T-cell depletion is mediated predominantly by macrophages, but the Fas/FasL pathway selectively targets regulatory T cells.
    Neff KS; Richards SM; Williams JM; Garman RD; Ruzek MC
    Transplantation; 2011 Sep; 92(5):523-8. PubMed ID: 21804441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.